UPCC 15124 Genotyping of BRCA1/2 mutation carriers (CIMBA)

Enrolling By Invitation

99 years or below

All

Phase N/A

1 Location

Brief description of study

The purpose of this protocol is to send the pre-collected and shelved DNA samples (parent protocol IRB #376800) from patients fitting the study eligibility requirements for genotyping at the Center for Inherited Disease Research (CIDR) at Johns Hopkins University. The samples will be used in genome-wide association studies (GWAS), which have the potential for discovery of associations among genetic variants and breast cancer susceptibility.

With the submission of this protocol, we request a letter of certification from the institution.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 99 years or below
Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 13-0026

If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator